Literature DB >> 20562467

Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics.

Bradford C Dickerson1, David A Wolk.   

Abstract

OBJECTIVE: To investigate whether some patients with very mild Alzheimer's disease (AD) demonstrate disproportionate executive dysfunction relative to amnesia and how this relates to functional impairment in daily life, future clinical decline, APOE genotype and regional cortical thickness measured from MRI scan data.
METHODS: The Alzheimer's Disease Neuroimaging Initiative dataset was interrogated for a primary sample of patients with very mild AD dementia (n=100) and a secondary confirmatory sample of patients with mild cognitive impairment (n=396). An executive predominant subgroup was defined as having executive performance ≥2 SDs worse than memory performance and a memory predominant subgroup was defined conversely. A priori regions of interest from a previous study of an AD patient sample were used to obtain cortical thickness measures.
RESULTS: Despite equivalent global measures of impairment (Mini-Mental State Examination, Clinical Dementia Rating (CDR) Sum of Boxes), executive predominant patients (n=88) were more impaired on other executive measures and in the CDR Judgement and Problem Solving box (p<0.005) while memory predominant patients (n=56) were more impaired on other memory measures (p<0.05). The APOE-ε4 allele was much more frequent in the memory predominant subgroup (p<0.0001). Frontoparietal cortical regions were thinner in the executive predominant group than in the memory predominant group (p<0.05).
CONCLUSIONS: A dysexecutive clinical phenotype of very mild AD is not rare and is associated with more problem solving difficulties and possibly more rapid progression compared with patients with a predominant amnesic phenotype. Executive predominant AD may reflect an alternative underlying pathophysiology related to genetic status, reflected in more prominent pathological alterations in frontoparietal regions subserving executive function. These findings, which deserve further investigation, may have implications for diagnosis, prognostication, monitoring and related issues involved in clinical research and care.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562467      PMCID: PMC3023235          DOI: 10.1136/jnnp.2009.199505

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  27 in total

Review 1.  Frontal lobes and human memory: insights from functional neuroimaging.

Authors:  P C Fletcher; R N Henson
Journal:  Brain       Date:  2001-05       Impact factor: 13.501

Review 2.  Control of goal-directed and stimulus-driven attention in the brain.

Authors:  Maurizio Corbetta; Gordon L Shulman
Journal:  Nat Rev Neurosci       Date:  2002-03       Impact factor: 34.870

3.  Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study.

Authors:  A Brun; L Gustafson
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-12-31

4.  APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.

Authors:  C Geroldi; M Pihlajamäki; M P Laakso; C DeCarli; A Beltramello; A Bianchetti; H Soininen; M Trabucchi; G B Frisoni
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

5.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

Review 6.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

7.  Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment.

Authors:  Judy Pa; Adam Boxer; Linda L Chao; Adam Gazzaley; Katie Freeman; Joel Kramer; Bruce L Miller; Michael W Weiner; John Neuhaus; Julene K Johnson
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

8.  The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.

Authors:  Akram Bakkour; John C Morris; Bradford C Dickerson
Journal:  Neurology       Date:  2008-12-24       Impact factor: 9.910

9.  Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.

Authors:  M Pievani; P E Rasser; S Galluzzi; L Benussi; R Ghidoni; F Sabattoli; M Bonetti; G Binetti; P M Thompson; G B Frisoni
Journal:  Neuroimage       Date:  2009-01-21       Impact factor: 6.556

10.  The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.

Authors:  Bradford C Dickerson; Akram Bakkour; David H Salat; Eric Feczko; Jenni Pacheco; Douglas N Greve; Fran Grodstein; Christopher I Wright; Deborah Blacker; H Diana Rosas; Reisa A Sperling; Alireza Atri; John H Growdon; Bradley T Hyman; John C Morris; Bruce Fischl; Randy L Buckner
Journal:  Cereb Cortex       Date:  2008-07-16       Impact factor: 5.357

View more
  70 in total

Review 1.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

2.  Naming impairment in Alzheimer's disease is associated with left anterior temporal lobe atrophy.

Authors:  Kimiko Domoto-Reilly; Daisy Sapolsky; Michael Brickhouse; Bradford C Dickerson
Journal:  Neuroimage       Date:  2012-06-21       Impact factor: 6.556

Review 3.  Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.

Authors:  Meredith N Braskie; Paul M Thompson
Journal:  Trends Cogn Sci       Date:  2013-09-09       Impact factor: 20.229

4.  Fractionating the Rey Auditory Verbal Learning Test: Distinct roles of large-scale cortical networks in prodromal Alzheimer's disease.

Authors:  Deepti Putcha; Michael Brickhouse; David A Wolk; Bradford C Dickerson
Journal:  Neuropsychologia       Date:  2019-03-28       Impact factor: 3.139

5.  Dysexecutive versus amnestic Alzheimer disease subgroups: analysis of demographic, genetic, and vascular factors.

Authors:  Jesse Mez; Stephanie Cosentino; Adam M Brickman; Edward D Huey; Jennifer J Manly; Richard Mayeux
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jul-Sep       Impact factor: 2.703

6.  Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation.

Authors:  Ryan A Townley; Angelina J Polsinelli; Julie A Fields; Mary M Machulda; David T Jones; Jonathan Graff-Radford; Kejal M Kantarci; Val J Lowe; Rosa V Rademakers; Matt C Baker; Neeraj Kumar; Bradley F Boeve
Journal:  Neurocase       Date:  2020-06-30       Impact factor: 0.881

7.  Approach to atypical Alzheimer's disease and case studies of the major subtypes.

Authors:  Bradford C Dickerson; Scott M McGinnis; Chenjie Xia; Bruce H Price; Alireza Atri; Melissa E Murray; Mario F Mendez; David A Wolk
Journal:  CNS Spectr       Date:  2017-02-15       Impact factor: 3.790

Review 8.  [Innovation in diagnostics-mobile technologies].

Authors:  Emrah Düzel; Jochen René Thyrian; David Berron
Journal:  Nervenarzt       Date:  2019-09       Impact factor: 1.214

9.  Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.

Authors:  Stéphane P Poulin; David Bergeron; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  Alzheimer's disease first symptoms are age dependent: Evidence from the NACC dataset.

Authors:  Josephine Barnes; Bradford C Dickerson; Chris Frost; Lize C Jiskoot; David Wolk; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2015-04-24       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.